Market Overview - The textile and apparel sector in A-shares has outperformed the broader market since February, with the textile manufacturing index rising by 3.6% and the brand apparel index by 2.0% [11] - The Hong Kong textile and apparel index has increased by 4.4% since February, also outperforming the market [11] - Notable companies with significant stock price increases include Under Armour (14.9%), Amer Sports (9.7%), and Jiangnan Buyi (9.6%) [11] Brand Apparel Insights - In December, the year-on-year growth of clothing retail sales was 0.6%, with a slowdown in growth compared to previous months [5] - January saw a 32.5% decline in operating income for sports retailer BaoSheng International, attributed to the timing of the Spring Festival [5] - E-commerce sales in January rebounded, driven by promotional activities and pre-holiday purchases, with outdoor apparel leading growth at 17% year-on-year [5] - Key brands showing strong growth in the sports apparel category include Lululemon (47%), Descente (29%), and Adidas (16%) [5] Textile Manufacturing Insights - Vietnam's textile exports increased by 8.3% year-on-year in January, while footwear exports rose by 7.8% [5] - The macroeconomic environment shows mixed signals, with PMI in Indonesia and India rising, while Vietnam's PMI slightly decreased but remains above 50 [5] - Wool prices have increased by 15.3% year-to-date, with a year-on-year increase of 54.9% as of February 5 [5] - Companies like RuHong and GuangYue are experiencing revenue growth due to order continuity and optimized production structures [5] Annual Performance Forecasts - Several companies in the textile and apparel sector, including Bailong Dongfang and Tianhong International, have issued profit forecasts indicating over 40% growth in net profit [2] - Factors contributing to this growth include full order books, improved capacity utilization, and declining raw material costs [2] Investment Recommendations - The report suggests focusing on brands that are likely to benefit from the Spring Festival sales surge and the performance elasticity of upstream suppliers [5] - High-end consumer recovery is anticipated, particularly in the light luxury sports and outdoor segments [5] - Key recommendations include Anta Sports, Li Ning, and Xtep International, which are well-positioned to capture market growth [5] Key Company Earnings Forecasts - Anta Sports is rated "Outperform" with an expected EPS of 4.72 for 2025 and 4.98 for 2026 [6] - Li Ning is also rated "Outperform" with an expected EPS of 1.01 for 2025 and 1.08 for 2026 [6] - Other companies such as Xtep International and 361 Degrees are similarly rated "Outperform" with positive earnings forecasts [6]

Investment Rating - The report gives an "Outperform" rating for the company [5][3] Core Views - The company is expected to see profit recovery in the first three quarters of 2025, with revenue reaching 30.24 billion yuan, a year-on-year increase of 4.94%, and a net profit of 999.2 million yuan, up 5.15% year-on-year [1][26] - The management team has been rejuvenated with a core group of individuals born in the 1980s, which is expected to enhance governance and operational efficiency [1][22] - The company is strategically positioned in military aircraft and military trade, with a solid product matrix for military transport aircraft and ongoing development of special aircraft based on the Y-20 platform [2][41] - In the civil aviation sector, the company is set to benefit from the growth of the C919 aircraft and is actively engaging in the low-altitude economy, which is projected to be a trillion-yuan market [2][57] Summary by Sections Financial Performance - In the first three quarters of 2025, the company achieved a revenue of 30.24 billion yuan, with a significant quarterly revenue increase of 27.51% in Q3 [1][26] - The net profit margin reached 3.28%, marking a recent high for the company [1][26] - The company’s revenue and profit are expected to continue growing, with projected net profits of 1.17 billion yuan, 1.34 billion yuan, and 1.52 billion yuan for 2025, 2026, and 2027 respectively [3][74] Business Segments - The military segment is solid, with the company being the sole producer of strategic transport aircraft in China, and the Y-20 has achieved mass production capabilities [2][41] - The civil aviation segment is expected to benefit from the C919 aircraft, with a projected market size of several hundred billion yuan over the next 20 years [2][57] - The company is also expanding into the low-altitude economy, with products like the HH-200 unmanned transport system, which is in the process of obtaining airworthiness certification [2][65] Management and Governance - The management team has undergone significant changes, with a focus on younger leadership, which is expected to improve decision-making and operational stability [1][22] - The new management structure includes several individuals with extensive experience in the aviation industry, indicating a strategic shift towards expertise-driven leadership [22][25] Market Position and Competitive Landscape - The company has established a strong foothold in both military and civil aviation markets, with a focus on high-performance military aircraft and a comprehensive product line for civil aviation [19][41] - The company’s operational efficiency is reflected in its low expense ratio, which is expected to support future profitability [38][30]

Investment Rating - The investment rating for Tianli International Holdings (01773.HK) is "Outperform the Market" (maintained) [2][16]. Core Views - The company is strategically expanding its enrollment of transfer students to counteract the previous slowdown in enrollment growth, with a target of approximately 7,000 transfer students for the fiscal year 2026, which is expected to increase the total number of students served by about 14% year-on-year [3][5]. - The AI education products are showing sustained effectiveness, accelerating revenue conversion. The AI Sprint Camp has reached 1,934 students as of January 26, 2026, with expectations to exceed 4,000 students for the year, projecting revenues of 0.88 billion, 1.54 billion, and 2.31 billion for FY2026, FY2027, and FY2028 respectively [3][8][11]. - The company forecasts revenues of 39.15 billion, 42.25 billion, and 44.99 billion for FY2026, FY2027, and FY2028, with corresponding growth rates of 9.1%, 7.9%, and 6.5%. Adjusted net profits are projected to be 7.41 billion, 8.21 billion, and 9.01 billion for the same periods, with growth rates of 11.5%, 10.9%, and 9.7% [3][16]. Summary by Sections Enrollment Strategy - The company is actively adjusting its enrollment strategy to address the short-term negative impact on enrollment growth. As of January 25, 2026, 3,603 transfer students have been enrolled, with a projected total of 14.8 million students served in FY2026, reflecting a year-on-year increase of approximately 14% [3][5]. - The strategy includes a slight relaxation of enrollment standards to increase student reserves while maintaining teaching quality [7]. AI Education Business - The AI Sprint Camp business is accelerating its commercialization, with expected revenue conversion of 0.88 billion for FY2026. The program has shown significant improvement in student performance, with a notable increase in the number of students covered [8][10]. - The AI system, developed by the company's subsidiary, aims to enhance educational outcomes, particularly for students who are lagging behind [10]. Share Buyback and Investor Confidence - The company announced a share buyback plan, intending to repurchase up to 200 million HKD worth of shares in the open market, which is expected to enhance investor confidence [3][12].

Investment Rating - The investment rating for Tianli International Holdings (01773.HK) is "Outperform the Market" (maintained) [2][16]. Core Views - The company is strategically expanding its enrollment of transfer students to counteract the previous slowdown in enrollment growth, with a target of approximately 7,000 transfer students for the fiscal year 2026, which is expected to increase the total number of students served by about 14% year-on-year [3][5]. - The effectiveness of the AI education products is being continuously validated, leading to accelerated revenue conversion. The AI Sprint Camp has reached 1,934 students, with expectations to exceed 4,000 students for the fiscal year 2026, generating projected revenues of CNY 88 million [3][8][11]. - Revenue forecasts for FY2026 to FY2028 are projected at CNY 39.15 billion, CNY 42.25 billion, and CNY 44.99 billion, respectively, with corresponding growth rates of 9.1%, 7.9%, and 6.5% [3][16]. Summary by Sections Enrollment Strategy - The company is actively adjusting its enrollment strategy to address the short-term negative impact on enrollment growth. As of January 25, 2026, 3,603 transfer students have been enrolled, with a projected total of 14.8 million students served in FY2026, reflecting a year-on-year increase of approximately 14% [3][5]. - The strategy includes a slight relaxation of enrollment standards to increase student reserves while maintaining teaching quality [7]. AI Education Business - The AI Sprint Camp business is accelerating its commercialization, with expected revenue conversion of CNY 88 million for FY2026. The program has shown significant improvement in student performance, with an average score increase of 48 points for nearly 1,000 students in the latest pilot [8][10]. - The AI education system, developed by the company's subsidiary, aims to provide additional educational resources to students who are lagging behind, thereby enhancing overall school performance and reputation [10][11]. Share Buyback and Investor Confidence - The company announced a share buyback plan, intending to repurchase up to CNY 200 million worth of shares in the open market, which is expected to enhance investor confidence [3][12].

Macro and Strategy - The macro review highlights a significant increase in PPI month-on-month, with January 2026 CPI showing a year-on-year increase of 0.2% and PPI down by 1.4% compared to the previous year [5][6] - The Hang Seng Technology Index has faced a downturn, failing to experience the expected post-Lunar New Year rally, with a notable shift in investment from high-growth tech stocks to dividend-paying assets [5][6] - The report discusses the performance of various asset classes, indicating a decline in equity indices and mixed results in commodity prices, with WTI crude oil rising by 2.75% [5][6] Industry and Company - The internet industry report emphasizes the growth potential of AI applications, with major companies like SpaceX and Meta making significant advancements in AI technology [13][14] - The pharmaceutical industry report suggests a focus on undervalued sectors, particularly in medical services and consumer-related segments, anticipating a recovery in 2026 [15][16] - China Uranium Industry (001280.SZ) is highlighted for its strong position in the natural uranium market, with a projected production of 3,955 tons in 2024, accounting for 6.4% of global output [17][18] - Bilibili (09626.HK) is expected to benefit from increased advertising revenue in 2026 due to the gaming industry's growth and the rise of AI applications [19][20] - Semiconductor company SMIC (00981.HK) reported a revenue of $2.489 billion in Q4 2025, exceeding guidance, with expectations for growth in 2026 to surpass industry averages [21][22] - Lianchuang Optoelectronics (600363.SH) is focusing on high-temperature superconductors and laser technology, with a projected net profit growth of 19.4% in 2025 [25][26]

证券研究报告 | 2026年02月10日 2026年02月11日 中芯国际（00981.HK） 优于大市 四季度收入超指引上限，预计 2026 年增速高于可比同业均值 4Q25 营收超指引上限，预计 2026 年收入增幅高于可比同业均值。公司 4Q25 实现销售收入 24.89 亿美元（YoY +12.8%，QoQ +4.5%），高于指引(QoQ 0%-2%) 上限，续创季度收入新高，晶圆收入占总收入的 92.4%；毛利率因折旧增加 降至 19.2%(YoY -3.4pct，QoQ -2.7pct)，符合指引；归母净利润为 1.73 亿 美元(YoY +60.7%，QoQ -10.0%)。预计 1Q26 营收环比持平，毛利率为 18%-20%， 2026 年全年收入增幅高于可比同业平均值。 四季度产能利用率环比基本持平，预计 2026 年资本开支与 2025 年持平。公 司 4Q25 付运折合 8 英寸晶圆 251 万片(YoY +26.3%，QoQ +0.6%)，产能利用 率为 95.7%(YoY +10.2pct，QoQ -0.1pct)。在晶圆收入中 12 英寸晶圆贡献 77.2%，8 英寸晶圆贡献 2 ...

Investment Rating - The report initiates coverage with an "Outperform" rating for the company [3][5]. Core Views - The company has achieved a significant improvement in its financial performance, with a notable increase in net profit and revenue in the first three quarters of 2025, indicating a turning point in its business trajectory [1][21]. - The focus on "Laser + High-Temperature Superconductors" is optimizing the company's industrial structure, leading to enhanced profitability and growth potential in high-value sectors [2][14]. - The company is well-positioned to benefit from the growing demand in the laser and high-temperature superconducting markets, particularly in commercial aerospace and defense applications [23][40]. Financial Performance Summary - For the first three quarters of 2025, the company reported a revenue of 2.503 billion yuan, a year-on-year increase of 2.83%, and a net profit of 400 million yuan, up 19.40% year-on-year [1][8]. - The third quarter of 2025 saw a revenue of 856 million yuan, down 3.49% year-on-year but up 1.06% quarter-on-quarter, with a net profit of 137 million yuan, reflecting a 28.04% year-on-year increase [1][21]. - The gross margin for the first three quarters of 2025 was 19.73%, an increase of 3.84 percentage points year-on-year, while the net margin was 16.48%, also reflecting a significant improvement [8][25]. Earnings Forecast and Financial Metrics - The company is projected to achieve net profits of 477 million yuan, 584 million yuan, and 661 million yuan for 2025, 2026, and 2027 respectively, indicating growth rates of 97.9%, 22.3%, and 13.2% [4][3]. - Earnings per share (EPS) are expected to be 1.05 yuan, 1.28 yuan, and 1.45 yuan for the same years, with dynamic price-to-earnings (PE) ratios of 60, 49, and 44 [4][3]. - The report estimates the reasonable stock value to be between 72.4 and 75.1 yuan, suggesting a premium of 14.6% to 18.9% over the current stock price of 63.17 yuan [3][5]. Industry Positioning and Strategic Focus - The company is strategically positioned in the laser and high-temperature superconducting sectors, with a complete industrial chain from core components to system integration [40][47]. - The focus on high-temperature superconductors is expected to drive significant growth, particularly in applications related to controlled nuclear fusion and advanced manufacturing technologies [52][59]. - The company is also exploring opportunities in the commercial aerospace sector, leveraging its technological advancements in electromagnetic launch systems [66][74].

- The report does not contain any quantitative models or factors for analysis [1][2][3][4]

策略周报 每周海内外重要政策跟踪 国内宏观：2 月 2 日，中共中央、国务院发布关于《现代化首都都市圈空间 协同规划（2023－2035 年）》；同日，商务部等九单位启动 2026"乐购新 春"春节特别活动，促进假期消费。2 月 3 日，国务院国资委党委召开专题 党委会议，提出要大力发展战略性新兴产业和未来产业。2 月 4 日，中国人 民银行召开 2026 年信贷市场工作会议要求不断加强对重大战略、重点领域 和薄弱环节的优质金融服务。 2 月 5 日，财政部等三部门发布海南自由贸 易港岛内居民消费的进境商品"零关税"政策；同日，国家网信办等 11 部 门联合印发《关于提升境外人员入境数字化服务便利性的实施意见》。2 月 7 日，国家数据局、工业和信息化部、公安部、证监会联合发布《关于培育 数据流通服务机构 加快推进数据要素市场化价值化的意见》，首次明确我 国将培育三类数据流通服务机构，包括数据交易所（中心）、数据流通服务 平台企业和数据商。2 月 8 日，央行公布中国 1 月末黄金储备报 7419 万盎司， 为连续第 15 个月增持黄金。 证券研究报告 | 2026年02月11日 产业政策：2 月 2 日，市 ...

Core Insights - The report emphasizes the focus on undervalued and performance-recovering sectors within the medical services and consumer segments, predicting a fundamental improvement in 2026 [4]. Group 1: Investment Strategy - The report maintains an "outperform" rating for the sector, indicating a positive outlook for the medical and consumer-related segments [2]. - Key areas of focus include medical services, pharmacies, and home medical devices, which are expected to see performance recovery and valuation improvements in 2026 [4]. Group 2: Sector Analysis - Medical services are anticipated to recover due to improved supply structure and consumer environment, with leading companies expected to show positive earnings guidance for 2026 [4]. - The pharmacy sector has shown significant marginal improvement since Q3 2025, with leading companies experiencing quarterly performance enhancements [4]. - Home medical devices are expected to benefit from increased product penetration and domestic production rates, contributing to sustained performance growth [4]. Group 3: Notable Companies - The report highlights specific companies to watch, including Aier Eye Hospital, Yuyue Medical, and Yifeng Pharmacy, which are positioned for growth in their respective segments [4]. - The investment portfolio for February 2026 includes a mix of A-share and H-share companies, such as Mindray Medical, WuXi AppTec, and Kangfang Biotech, indicating a diversified approach to investment [4]. Group 4: Market Performance - The medical sector outperformed the broader market in January 2026, with a 3.14% increase compared to the 1.49% rise of the CSI 300 index [10]. - Sub-sectors such as medical services and medical devices showed significant gains, with respective increases of 8.82% and 5.28% [17]. Group 5: Macro Data - In 2025, the pharmaceutical manufacturing industry reported a total revenue of 24,870 billion yuan, reflecting a slight decline of 1.2% year-on-year, while total profits increased by 2.7% [9]. - The retail sales of pharmaceuticals reached 7,294 billion yuan, with a year-on-year growth of 1.8%, indicating a stable demand in the market [9].